Optimal Individualized Treatments in Resource-Limited Settings

International Journal of Biostatistics

Volumn 12, Issue 1, 2016, Pages 283-303

  Luedtke, Alexander R ^a   Van Der Laan, Mark J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asymptotic linearity; efficient influence curve; individualized treatments; influence curve; resource constraint

Indexed keywords

HUMAN; PROBABILITY; STATISTICAL MODEL; STOCHASTIC MODEL; ECONOMICS; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PROCEDURES; STANDARDS; THEORETICAL MODEL;

HUMANS; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); PRECISION MEDICINE;

EID: 84975256229     PISSN: None     EISSN: 15574679     Source Type: Journal    
DOI: 10.1515/ijb-2015-0007     Document Type: Article

References (33)

1. Murphy SA. Optimal dynamic treatment regimes. J Roy Stat Soc Ser B 2003;650:331-6.
2. Robins JM. Optimal structural nested models for optimal sequential decisions. In: DY Lin and Heagerty P, editors. Proc. Second Seattle Symp. Biostat, 179, 2004:189-326.
3. Chakraborty B, Moodie EE. Statistical methods for dynamic treatment regimes. Berlin, Heidelberg, New York: Springer, 2013.
4. Arjas E, Jennison C, Dawid AP, Cox DR, Senn S, Cowell RG, et al. Optimal dynamic treatment regimes-discussion on the paper by murphy. J Roy Stat Soc Ser B 2003;65:355-66.
5. Lasry A, Sansom SL, Hicks KA, Uzunangelov V. A model for allocating CDCs HIV prevention resources in the United States. Health Care Manag Sci 2011;140:115-24.
6. Tao G, Zhao K, Gift T, Qiu F, Chen G. Using a resource allocation model to guide better local sexually transmitted disease control and prevention programs. Oper Res Heal Care 2012;10:23-9.
7. Karp RM. Reducibility among combinatorial problems. New York, Berlin, Heidelberg: Springer, 1972.
8. Korte B, Vygen J. Combinatorial optimization, 5th ed. Berlin, Heidelberg, New York: Springer, 2012.
9. Dantzig GB. Discrete-variable extremum problems. Oper Res 1957;50:266-88.
10. Zhang B, Tsiatis A, Davidian M, Zhang M, Laber E. A robust method for estimating optimal treatment regimes. Biometrics 2012;68:1010-18.
11. Vander Laan MJ, Luedtke AR. Targeted learning of an optimal dynamic treatment, and statistical inference for its mean outcome. Technical report 329. Available at: http://www.Bepress.Com/Ucbbiostat/, Division of Biostatistics, University of California, Berkeley, 2014a.
12. Goldberg Y, Song R, Zeng D, Kosorok MR. Comment on dynamic treatment regimes: technical challenges and applications. Electron J Stat 2014;8:1290-300.
13. Luedtke AR, Vander Laan MJ. Statistical inference for the mean outcome under a possibly non-unique optimal treatment strategy. Technical Report 332. Available at: http://biostats.bepress.com/ucbbiostat/paper332/, Division of Biostatistics, University of California, Berkeley, submitted to Annals of Statistics, 2014b.
14. Chakraborty B, Laber EB, Zhao Y-Q. Inference about the expected performance of a data-driven dynamic treatment regime. Clin Trials 2014;110:408-17.
15. Pearl J. Causality: models, reasoning and inference, 2nd ed. New York: Cambridge University Press, 2009.
16. Robins JM. A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. Comput Math Appl 1987;140:139s-161s. ISSN 0097-4943.
17. Daz I, Vander Laan MJ. Population intervention causal effects based on stochastic interventions. Biometrics 2012;680: 541-9.
18. Luedtke AR, Vander Laan MJ. Super-learning of an optimal dynamic treatment rule. Technical Report 326. Available at: http://www.bepress.com/ucbbiostat/, Division of Biostatistics, University of California, Berkeley, under Review at JCI, 2014a.
19. Vander Laan MJ, Polley E, Hubbard A. Super learner. Stat Appl Genet Mol 2007;60. Article 25.ISSN 1.
20. Vander Laan MJ, Luedtke AR. Targeted learning of the mean outcome under an optimal dynamic treatment rule. J Causal Inference 2014b. (Ahead Of print). DOI: 10.1515/jci-2013-0022.
21. Vander laan MJ, Robins JM. Unified methods for censored longitudinal data and causality. New York, Berlin, Heidelberg: Springer, 2003.
22. Pfanzagl J. Estimation in semiparametric models. Berlin, Heidelberg, New York: Springer, 1990.
23. Bickel PJ, Klaassen CAJ, Ritov Y, Wellner JA. Efficient and adaptive estimation for semiparametric models. Baltimore: Johns Hopkins University Press, 1993.
24. Audibert JY, Tsybakov AB. Fast learning rates for plug-in classifiers. Ann Statist 2007;350:608-33.
25. Vander Vaart AW, Wellner JA. Weak convergence and empirical processes. Berlin, Heidelberg, New York: Springer, 1996.
26. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2014. Available at: http://www.r-project.org
27. Vander Laan MJ, Rose S. Targeted learning: causal inference for observational and experimental data. New York: Springer, 2011.
28. Rubin DB, Vander laan MJ. Statistical issues and limitations in personalized medicine research with clinical trials. Int J Biostat 2012;8:article 18.
29. Zhao Y, Zeng D, Rush A, Kosorok M. Estimating individual treatment rules using outcome weighted learning. J Am Stat Assoc 2012;107:1106-18.
30. Zhao YQ, Zeng D, Laber EB, Kosorok MR. New statistical learning methods for estimating optimal dynamic treatment regimes. J Am Stat Assoc 2014.
31. Brock DW, Wikler D. Ethical challenges in long-term funding for HIV/AIDS. Health Aff 2009;280:1666-76.
32. Macklin R, Cowan E. Given financial constraints, it would be unethical to divert antiretroviral drugs from treatment to prevention. Health Aff 2012;310:1537-44.
33. Singh JA. Antiretroviral resource allocation for HIV prevention. AIDS 2013;270:863-5.